Audited Results of Marksans Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	1,174.37	853.27	655.20	658.29	599.55
Manufacturing Expenses	30.73	26.04	14.24	11.27	10.90
Personnel Expenses	101.68	77.19	56.09	60.46	54.64
Selling Expenses	0	0	0	0	0
Administrative Expenses	197.98	131.17	98.52	95.25	82.38
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	970.32	713.34	563.30	544.57	485.84
Operating Profit	204.05	139.94	91.90	113.72	113.71
Other Recurring Income	69.83	62.07	60.48	42.25	31.16
Adjusted PBDIT	273.88	202.01	152.38	155.97	144.87
Financial Expenses	1.17	0.99	3.61	3.79	5.34
Depreciation	29.45	29.13	16.74	17.66	15.19
Other Write offs	0	0	0	0	0
Adjusted PBT	243.26	171.89	132.03	134.51	124.33
Tax Charges	54.99	38.13	29.17	30.52	25.95
Adjusted PAT	188.27	133.76	102.87	103.99	98.38
Non Recurring Items	-0.30	0.28	-0.59	0.05	-0.20
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	188.27	133.76	102.87	103.99	98.38
Equity Dividend	27.19	22.66	10.17	10.23	4.09
Preference Dividend	0	0	0	0	0
Retained Earnings	505.78	345	247.31	155.21	61.41

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article